EMPOWERPHARM Trademark

Trademark Overview

On Tuesday, October 26, 2021, a trademark application was filed for EMPOWERPHARM with the United States Patent and Trademark Office. The USPTO has given the EMPOWERPHARM trademark a serial number of 97092448. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 1, 2025. This trademark is owned by EmpowerPharm Inc.. The EMPOWERPHARM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing medical and scientific research information in the field of pharmaceuticals
empowerpharm

General Information

Serial Number97092448
Word MarkEMPOWERPHARM
Filing DateTuesday, October 26, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, October 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkEMPOWER PHARM
Goods and Servicesproviding medical and scientific research information in the field of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpowerPharm Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, Ontario L7L6M1
CA

Trademark Events

Event DateEvent Description
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 29, 2021NEW APPLICATION ENTERED
Friday, August 5, 2022ASSIGNED TO EXAMINER
Wednesday, August 3, 2022ASSIGNED TO EXAMINER
Wednesday, October 5, 2022ASSIGNED TO EXAMINER
Tuesday, October 11, 2022NON-FINAL ACTION WRITTEN
Tuesday, October 11, 2022NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 21, 2023SUSPENSION LETTER WRITTEN
Friday, April 21, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 21, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 2, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 13, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, June 10, 2025SUSPENSION INQUIRY WRITTEN
Tuesday, June 10, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, June 10, 2025INQUIRY TO SUSPENSION E-MAILED
Wednesday, October 1, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 1, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, December 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

empowerpharm field pharmaceuticals information research medical scientific providing